Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02004262
Title Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Aduro BioTech, Inc.
Indications

pancreatic adenocarcinoma

Therapies

Irinotecan

Erlotinib

Cyclophosphamide

Capecitabine + Fluorouracil + Gemcitabine

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.